期刊文献+

云南省三个民族人群幽门螺杆菌甲硝唑耐药调查 被引量:14

Study on metronidazole resistance to Helicobacter pylori from three populations with different ethnics in Yunnan
原文传递
导出
摘要 目的 调查和分析云南省不同民族幽门螺杆菌(H.pylori)菌株对甲硝唑耐药的流行情况。方法 用E-test方法检测109株H.pylori菌株(汉族人群分离33株、白族31株、纳西族45株)对甲硝唑的敏感性。结果 云南地区甲硝唑耐药率为67.89%。汉族、白族、纳西族H.pylori对甲硝唑耐药率在统计学上差异无显著性。云南地区和三个民族H.pylori菌株的甲硝唑耐药率在年龄、上消化道疾病的分布上差异无显著性;但在性别方面,汉族男性组甲硝唑耐药率为50.00%,低于女性组的90.91%(X^2=5.304,P=0.027);而白族和纳西族中性别在H.pylori对甲硝唑耐药率上差异无显著性。结论 云南地区H.pylori对甲硝唑耐药率高,汉族、白族、纳西族在选择治疗H.pylori感染的抗生素时,可以忽略民族间的差异。 Objective To evaluate the prevalence of Helicobacter pylori (H. pylori ) resistance to metronidazole among three populations in Yunnan. Methods Susceptibilities to metronidazole among 109 H. pylori strains(33 H. pylori strains from Han, 31 H. pylori strains from Bai and 45 H. pylori strains from Naxi ethnic populations)were tested by Epsilometer test(E-test). Results In 109 H. pylori strains, the overall metronidazole resistantce rate was 67.89%. There were no significant difference in the metronidazole resistant rates of H. pylori among Han, Bai, Naxi populations Yunnan in terms of the distribution on age and upper gastroduodenal diseases. In the facet of gender, metronidazole resistant rate of H. pylori was significantly lower in Han males than in females(X^2=5. 304, P=0. 027), but not seen in the Bai or Naxi peoples. Conclusion Metronidazole resistance rate of H. pylori in Yunnan was high, but no significant difference was found among Han, Bai, Naxi peoples in the province.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2004年第11期986-988,共3页 Chinese Journal of Epidemiology
关键词 甲硝唑 耐药率 幽门螺杆菌 调查 人群 汉族 治疗 云南省 显著性 差异 Helicobacter pylori Metronidazole Resistance
  • 相关文献

参考文献6

二级参考文献38

  • 1张万岱,吴炎,杨海涛,周殿元,吴鸿悌,宋家信,高河元,吴昌信,梁冠峰,冯伟勋,王斌会,颜光宇.胃癌自然人群幽门螺杆菌感染的血清流行病学调查[J].中华消化杂志,1995,15(5):276-278. 被引量:55
  • 2李伟,王学春,李星.胃幽门螺杆菌感染与胃癌发生关系的病理学观察[J].肿瘤防治研究,1996,23(3):135-136. 被引量:6
  • 3刘之武,李平,谢蓓,杨萍.天津地区部分人群幽门螺杆菌感染现状[J].新消化病学杂志,1996,4(12):718-718. 被引量:2
  • 4[1]Walsh JH,Peterson WL. The treatment of Helicobacter pylori infection in the managementof peptic ulcer disease. N Engl J Med 1995;333:984-991
  • 5[2]Franzin L, Pennazio M, Cabodi D, Paolo Rossini F, Gioannini P. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol 2000;40:96-100
  • 6[3]Kihira K, Satoh K, Saifuku K, Kawakami K, Ishino Y, Kimura K, SuK. Rabeprazole, amoxycillin and low- or high- dose clarithromycin for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14:1083-1087
  • 7[4]Houben MH, Hensen EF, Rauws EA, Hulst RW, Hoff BW, Ende AV, Kate FJ, Tytgat GN. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. Aliment Pharmacol Ther 1999;13:883-889
  • 8[5]Sakurai K, Takahashi, Yamaguchi Y, Yamada M, Kirihara K, KojimaT, Fujita R.Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori. Nippon Riinsho 1999;57:72-75
  • 9[6]Sharaara AI, Chedid M, Arai GF, Barada KA, Mourad FH. Prevalence of Helicobacter pylori resistance to metronidazole, elarithromycin, amoxycillin and tetracycline in Lelanon. Int J Antimierob Agents 2002;19:155-158
  • 10[7]Dunn BE,Cohen H, Blast MB Helicobacter pylori. Lin Microbiol Rev 1997;40:720-741

共引文献220

同被引文献131

引证文献14

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部